Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indicationsImport of coca leaves...
AdMeTech Foundation's 7th Annual Global Summit Brings Together the Key International Opinion Leaders for Accelerating Advancement of Research, Clinical Care...
BOULDER, CO / ACCESSWIRE / September 21, 2023 / Wellena is thrilled to introduce you to "Happy Sisters", the highly...
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ:...
Advanced technology enhances Intracept Procedure training for the treatment of vertebrogenic painCHICAGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- IPSIS Annual...
TEMPLE CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cage-Free Repair announced today that it has released its annual 2023...
Company announces 1-for-20 reverse stock splitNEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
FORT LEE, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and...
CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced...
FDA Orphan Drug Designation (“ODD”) qualifies one-time treatment NXC-201 for: 7 years of U.S. market exclusivity after approval Tax credits...
WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...
Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakevenPLEASANTON,...
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in...
Intelligent Bio Solutions at the 2023 Workplace Health & Safety Show Intelligent Bio Solutions at the 2023 Workplace Health &...
- 52 Relapsed and Refractory Lymphoma Patients Enrolled: 96% Alive at Last Assessment Indicating Favorable Survival Benefit - - Responses...
DALLAS, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gradalis, Inc., a privately held, clinical stage biotechnology company developing a personalized immunotherapy...
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa to Present Recruitment and Treatment Update in Phase 1 Study of MTX-110 (MAGIC-G1...
Financing led by Asteroid Partners with new investor Gideon Strategic Partners and returning investors Johnson and Johnson Development Corp., HM...
NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY,...
Live video webcast panel presentation on Tuesday, September 26th at 1:35 PM ETISELIN, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) --...